It is noteworthy that there was no association of MALAT1 status with the CLL-IPI, which predicts TTFT in newly diagnosed CLL patients when the whole cohort was analyzed, as well as when M-CLL and U-CLL subtypes were analyzed separately [58]. This evidence concerns the gene MALAT1 and B-cell chronic lymphocytic leukemia.